CD4 and tuberculosis: Our finding that there is an early decline in the Mtb specific CD8+ response during the initial phase of successful TB treatment suggests that the Mtb specific CD8+ T cell response, potentially by detecting intracellular bacterial burden, may be a more accurate, and direct surrogate of response to therapy than the CD4+ response.